The company aims to streamline the process of therapeutic protein production by providing an inexpensive, column-free, continuous, and single-use solution that replaces large-scale column chromatography processes used in biologics manufacturing. ChromaTan's CCTC platform has undergone extensive beta testing with major biotech companies and has consistently shown a 5-15X increase in throughput at an equivalent or better product quality. With its pioneering column-free, true moving bed chromatography process, ChromaTan is solving a major process bottleneck in therapeutic protein production while significantly lowering the cost of goods for biotech and contract manufacturing companies.